Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 346 (ZNF346) is a nucleolar protein with several C2H2-type zinc finger domains, which preferentially binds to double-stranded RNA (dsRNA) and RNA/DNA hybrids over DNA alone. Its zinc finger regions are essential for both dsRNA binding and localization to the nucleolus. ZNF346 may play a role in cell growth and survival and is involved in protecting neurons by inhibiting inappropriate cell cycle re-entry, partly through stimulating p21 gene expression. ZNF346 is not established as a classical drug target and does not have known approved therapeutics or biomarker roles as of now, though it has been detected as a fusion partner in some cancer gene fusions[1][5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 346 (ZNF346).